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Accepted 6 June 2016Major histocompatibility complex class I (MHC-I) proteins can be expressed as cell surface or secreted proteins.
To investigate whether bovine non-classical MHC-I proteins are expressed as cell surface or secreted proteins,
and to assess the reactivity pattern of monoclonal antibodies with non-classical MHC-I isoforms, we expressed
the MHC proteins inmurine P815 and human K562 (MHC-I deﬁcient) cells. Following antibiotic selection, stably
transfected cell lines were stained with H1A or W6/32 antibodies to detect expression of the MHC-I proteins by
ﬂow cytometry. Two non-classical proteins (BoLA-NC1*00501 and BoLA-NC3*00101)were expressed on the cell
surface in both cell lines. Surprisingly, the BoLA-NC4*00201 protein was expressed on the cell membrane of
human K562 but not mouse P815 cells. Two non-classical proteins (BoLA-NC1*00401, which lacks a transmem-
brane domain, and BoLA-NC2*00102) did not exhibit cell surface expression. Nevertheless,Western blot analyses
demonstrated expression of theMHC-I heavy chain in all transfected cell lines. Ammonium-sulfate precipitation
of proteins from culture supernatants showed that BoLA-NC1*00401 was secreted and that all surface expressed
proteins where shed from the cell membrane by the transfected cells. Interestingly, the surface expressedMHC-I
proteins were present in culture supernatants at a much higher concentration than BoLA-NC1*00401. This com-
prehensive study shows that bovine non-classical MHC-I proteins BoLA-NC1*00501, BoLA-NC3*00101, and
BoLA-NC4*00201 are expressed as surface isoforms with the latter reaching the cell membrane only in K562
cells. Furthermore, it demonstrated that BoLA-NC1*00401 is a secreted isoform and that signiﬁcant quantities
of membrane associated MHC-I proteins can be shed from the cell membrane.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Non-classical MHC class I1. Introduction
The major histocompatibility complex (MHC) in cattle is known as
the bovine leukocyte (or lymphocyte) antigen (BoLA) complex
(Davies et al., 1994a, b, 1997). The Immuno Polymorphism Database
(IPD-MHC) is the ofﬁcial database for MHC nomenclature (Ellis et al.,
2006; Hammond et al., 2012; Robinson et al., 2005). There are two sub-
classes of MHC class I (MHC-I) proteins: classical MHC-I and non-classi-
cal MHC-I. Classical MHC-I (MHC-Ia) proteins are membrane-bound
isoforms that are expressed in all nucleated cells of the body. Bovine
MHC-I haplotypes code for one to three expressed MHC-Ia proteins at
a minimum of six distinct loci (BoLA-1 through BoLA-6) (Birch et al.,icine, 4815 Old Main Hill, Utah
oscow, ID, USA.
. This is an open access article under2006; Codner et al., 2012; Ellis and Ballingall, 1999; Hammond et al.,
2012; Schwartz and Hammond, 2015). These proteins present intracel-
lular pathogen-derived peptides or autologous peptides to CD8 T cells
(Goddeeris et al., 1986a; Goddeeris et al., 1986b; Graham et al., 2008;
Guzman et al., 2008; Splitter et al., 1988). With the discovery of
human leukocyte antigen HLA-G (Ellis et al., 1986), another category
of MHC-I proteins, referred to as non-classical MHC-I (MHC-Ib), was
recognized. MHC-Ib molecules are less polymorphic, exhibit tissue spe-
ciﬁc expression patterns, possess speciﬁc molecular motifs in their
transmembrane domains, and/or contain premature stop codons.
MHC-Ib proteins are important immunomodulatory molecules that in-
teract with inhibitory and activating receptors on leukocytes. The
MHC-Ib proteins have been shown to induce immunotolerance to tu-
mors and play an important role in maternal tolerance to the conceptus
during human pregnancy (Garziera and Toffoli, 2014; Hunt et al., 2005;
Ishitani et al., 2006). Humans have three MHC-Ib genes – HLA-E, HLA-F
and HLA-G – and mice have two MHC-Ib gene – Qa-1 and Qa-2the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Vance et al., 1999; Zeng et al., 2012). There are four well characterized
bovine MHC-Ib genes: BoLA-NC1, BoLA-NC2, BoLA-NC3 and BoLA-NC4
(Birch et al., 2008a; Davies et al., 2006).
A unique characteristic of someMHC-Ib proteins is that they under-
go alternative splicing (differential splicing) to generatemembrane and
soluble isoforms. By virtue of this phenomenon, HLA-G produces mem-
brane-associated isoforms, HLA-G1, -G2, and -G3, and soluble isoforms,
HLA-G5 and -G6 (Ellis et al., 1986; Hunt et al., 2005). Similarly, murine
Qa-2 encodes two soluble isoforms S1 Qa-2 and S2 Qa-2 (Comiskey et
al., 2003),Mamu-AG in rhesusmonkeys encodesmembrane-bound iso-
formsMamu-AG1, -AG2 and -AG3 (Boyson et al., 1997), and Paan-AG in
baboons encodes fourmembrane isoforms, Paan-AG1, -AG2, -AG3 and -
AG4, and a soluble isoform, sPaan-AG1 (Langat et al., 2002). One of the
bovine non-classical MHC-I loci, BoLA-NC1, has also been shown to en-
code multiple, alternatively spliced transcripts (Araibi et al., 2006;
Birch et al., 2008a; Davies et al., 2006) (Davies and Schmidt, unpub-
lished). However, splice variants encoded at the other bovine MHC-Ib
loci – BoLA-NC2, -NC3, and -NC4 – have not been identiﬁed.
In humans, membrane bound and secreted non-classical class I mol-
ecules interact with inhibitory receptors expressed by natural killer
(NK) cells, T lymphocytes, and antigen presenting cells (APC) to inhibit
these immune cells (Bainbridge et al., 2000; Braud et al., 1998a; Ellis et
al., 1990; Ellis et al., 1986; Hunt et al., 2006; Hunt and Langat, 2009;
Hunt et al., 2005; Le Bouteiller, 2000; Park et al., 2004). The human
MHC-Ib molecule HLA-G interacts with leukocyte inhibitory receptors,
including leukocyte immunoglobulin-like receptors LILRB1 and LILRB2
and the killer immunoglobulin-like receptor KIR2DL4, to induce immu-
nosuppression (Clements et al., 2007; Comiskey et al., 2003;
Rajagopalan et al., 2006; Shiroishi et al., 2003). HLA-G also upregulates
expression of LILRB1, LILRB2, LILRB4, and KIR2DL4 in APC, NK cells and
T cells, which helps protect HLA-G expressing tissues from immune
cell attack (LeMaoult et al., 2005). HLA-E and its murine counterpart
Qa1 are ligands for activating and inhibitory members of the CD94/
NKG2 receptor family, which are encoded in the natural killer complex
(Braud et al., 1998a; Kelley et al., 2005; Vance et al., 1999; Zeng et al.,
2012). Cattle have genes encoding a wide variety of immunoglobulin-
like (LILR and KIR) and lectin-like (CD94/NKG2 receptor family) NK
cell receptors (Allan et al., 2015; Birch and Ellis, 2007; Boysen et al.,
2006; Dobromylskyj and Ellis, 2007; Govaerts and Goddeeris, 2001;
Guethlein et al., 2007; Hogan et al., 2012; McQueen et al., 2002;
Storset et al., 2004; Storset et al., 2003). It has been shown that the cattle
NKG2D receptor recognizes proteins encoded by twoMHC class I chain-
related (MIC) genes: MIC1 andMIC4 (Birch et al., 2008b; Guzman et al.,
2010). However, nothing is known about the ligands for the other bo-
vine activating and inhibitory NK cell receptors or if any of these recep-
tors recognize classical or non-classical MHC-I proteins.
It is likely that bovine non-classical MHC-I proteins are expressed as
both cell surface and secreted proteins. To investigate this hypothesis,
and to characterize monoclonal antibodies that react with different
non-classical MHC-I isoforms, bovine MHC-I proteins were expressed
in the murine mastocytoma cell line P815 and the human MHC-I deﬁ-
cient cell line K562. Cell-surface expression and the reactivity pattern
of MHC-I speciﬁc monoclonal antibodies were analyzed by ﬂow cytom-
etry. Secreted proteins in culture supernatants were precipitated using
ammonium sulfate and then detected using Western blots.
2. Materials and methods
2.1. Samples
Full-length MHC-I cDNAs were reverse transcribed from
interplacentomal trophoblast RNA, cloned in the pCRII-TOPO®
vector (Invitrogen), and stored at −80 °C as part of a previous
study (Davies et al., 2006). Two classical (BoLA-2*01802 and
BoLA-3*01701) and ﬁve non-classical (BoLA-NC1*00401, BoLA-NC1*00501, BoLA-NC2*00102, BoLA-NC3*00101 and BoLA-NC4*00201)
MHC-I isoforms were expressed for this study. The two classical MHC-I
proteins have previously been expressed by other investigators and
were included as positive controls for cell surface expression (Ellis
et al., 1999). We have previously shown that the ﬁve non-classical iso-
forms are transcribed in bovine trophoblast cells (Davies et al., 2006).
All of these isoforms were normally spliced isoforms except for the
BoLA-NC1*00401 isoform, which was a splice variant that lacked the
transmembrane domain.
2.2. Subcloning of classical and non-classical MHC class I genes
To facilitate expression in mammalian cell lines the MHC-I cDNAs
were subcloned from the pCRII-TOPO® sequencing vector (Invitrogen)
into the pcDNA3.1™D/V5-His-TOPO® directional mammalian expres-
sion vector (Invitrogen). Fifty microliter PCR reactions were prepared
by combining 1 U Platinum Pfx proofreading DNA Polymerase
(Invitrogen), 0.8 μM each of a forward and a reverse primer (listed
below), 2.0 mMMgSO4, 0.2 mM dNTPs, 1× optimized PCR buffer, and
2 μl of diluted (1:1000) pCRII-TOPO® plasmid. A single forward PCR
primer was used with two different reverse primers:rward primer (BoC1FP-E1B) ACCATGGGGCCGCGAACCCTC
everse primer (BoC1RP-3′A) GATGAAGCATCACTCAGTCCCC
everse primer (BoC1RP-E7A) TTTAGGAACCGTGAGAGACACATCRThe two reverse primers were used so that clones with the normal
stop codon (reverse primer BoC1RP-3′A) and clones expressing a 3′
6× histidine tag and V5 epitope (reverse primer BoC1RP-E7A) could
be produced. PCR ampliﬁcation was carried out using an Eppendorf
Mastercycler®with the followingparameters: 1min30 s at94 °C; 25cy-
cles of 30 s at 94 °C, 15 s at 60 °C and 90 s at 68 °C; 10min at 68 °C; hold
at 4 °C. PCR products were puriﬁed with the QIAquick PCR Puriﬁcation
Kit (Qiagen) and product size was conﬁrmed using 1% agarose gel elec-
trophoresis. Puriﬁed DNA was ligated into the pcDNA3.1™D/V5-His-
TOPO® expression vector for 5 min at room temperature, transformed
into TOP10F′ One Shot Competent Escherichia coli (Invitrogen), and
plated on LB agar containing 100 μg/ml ampicillin. Insert size in isolated
colonies was checked by PCR ampliﬁcation of lysed bacteria with T-7
forward and BGH reverse sequencing primers, which bind to sites with-
in the vector, followed by agarose gel electrophoresis. Only clones with
inserts of the expected size were considered for further evaluation.
2.3. Sequencing of subclones
Multiple subclones with the correct size insert were sequenced
using T-7 forward and BGH reverse sequencing primers. Plasmids
were puriﬁed using a QIAprep spin Miniprep Kit (Qiagen), and se-
quenced in both directions using a BigDye® Terminator v3.1 Cycle Se-
quencing Kit (Applied Biosystems) and ABI Prism® 3100 DNA
Analyzer (Applied Biosystems). Sequence analysis was done using
Lasergene SeqMan™ II and Meg-Align™ software (DNASTAR, Inc.).
Subclones with perfect sequences were selected for expression in the
mammalian cell lines.
2.4. Cell lines and transfection
P815 cells (ATCC TIB-64) are derived from a mastocytoma that de-
veloped in a mouse (Mus musculus) of the DBA/2 strain. The majority
of the mastocytoma cells grow in suspension (b5% adherent). Cells
were cultured in Dulbecco's Modiﬁed Eagle Medium (DMEM; Caisson
Laboratories) with 10% bovine calf serum (Hyclone), 2 mM L-glutamine
(Hyclone), 100 units/ml penicillin and 100 μg/ml streptomycin
(Hyclone) at 37 °C, 5% CO2.
The K562 cell line (ATCC CCL-243) is a MHC-I deﬁcient cell line de-
rived from a person with chronic myelogenous leukemia. These cells
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Medium (IMDM; Fisher Scientiﬁc) supplemented with 10% bovine calf
serum, 100 units/ml penicillin and 100 μg/ml streptomycin (Hyclone)
at 37 °C, 5% CO2. Both cell lines were obtained from American Type Cul-
ture Collection (ATCC, USA).
Cells were transfected with either a classical or non-classical MHC-I
gene in the pcDNA3.1 vector using Lipofectamine 2000 (Invitrogen)
transfection reagent according to themanufacturer's protocol. As a pos-
itive control P-815 cells were transfectedwith a plasmid encoding beta-
galactosidase supplied with the vector kit. Transfected cells were incu-
bated for 24 to 48 h prior to selection of stable transfectants by addition
of G418 (Invivogen) antibiotic (500 μg/ml). After twoweeks in selective
medium transfectants were screened by ﬂow cytometry.
2.5. Flow cytometry
The following monoclonal antibodies were used in the analysis. The
anti-bovine MHC-I monoclonal antibody H1A was used for screening
and sorting the transfected cell lines. Other anti-bovineMHC-I antibod-
ies that were also used included: H6A, H11A, H58A, PT85A (Davis et al.,
1987) and IL-A88 (Toye et al., 1990). The anti-human MHC-I monoclo-
nal antibody W6/32, which recognizes MHC-I heavy chains associated
with human or bovine beta-2-microglobulin (β2m), was used as a pos-
itive control for mouse P815 cells as these cells express mouse MHC-I
proteins that associate with bovine β2m present in the culture medium
(Bernabeu et al., 1985; Kahn-Perles et al., 1987). With the MHC-I deﬁ-
cient human K562 cells, W6/32 was negative on untransfected cells
but reacted with the bovine MHC-I proteins expressed by the
transfected cells. ColiS205D1 (IgG2a),which is speciﬁc for an Escherichia
coli antigen, was used as an isotype negative control for both cell lines.
All of the monoclonal antibodies except for IL-A88 were obtained from
the Monoclonal Antibody Center at Washington State University, Pull-
man, WA. The IL-A88 hybridoma was purchased from Sigma-Aldrich.
Fluorescein isothiocyanate (FITC) conjugated anti-mouse IgG antibody
(Kirkegaard & Perry Laboratories) was used as a secondary antibody.
For staining, cells were resuspended in ﬂuorescence buffer (PBS with
0.1% Sodium Azide, 1% bovine serum albumin) and incubated with pri-
mary antibody (15 μg/ml) for 15 min. Cells were washed twice with
ﬂuorescence buffer and then incubated with secondary antibody for
15 min. Cells were washed twice and ﬁxed in PBS with 1% formalde-
hyde. All incubations were performed at 4 °C. One million cells were
stained for each sample. Cells were analyzed using a BD Biosciences
FACSAria II ﬂuorescence activated cell sorter (FACS) equipped with
FACSDiva software. The FACSAria IIwas also used to sort the transfected
cells to enrich for high expressing cells. Flow cytometry ﬁgures for pub-
lication were created using FlowJo software (FlowJo, LLC).
2.6. Puriﬁcation of recombinant histidine tagged proteins
Transfected P815 and K562 cells were grown in T75 cell culture
ﬂasks (Corning). From each ﬂask approximately 100 × 106 cells were
harvested by centrifuging at 1500 RPM for 10min at room temperature.
Cells were washed in ice cold PBS, pH 7.2 and lysed in lysis buffer
(50 mM Tris, pH 7.8, 150 mM NaCl, 1% Nonidet P-40). One micromole
protease inhibitor cocktail (Sigma) for mammalian cell extracts and
1 mM PMSF (Phenyl Methane Sulfonyl Fluoride) were also added to
the suspension. Lysates were centrifuged at 10,000 RPM for 10 min at
4 °C and the supernatants were ﬁltered using 0.2 μM ﬁlters and stored
in sterile tubes at−20 °C until puriﬁed.
HisGraviTrap Columns (GE Healthcare) were used to purify the his-
tidine-tagged proteins. The manufacturer's recommended puriﬁcation
procedurewas followed. Puriﬁed eluateswere stored at−20 °C. Eluates
for each protein that had a strong band on a Western blot were pooled
and dialyzed against phosphate buffer solution (20 mM Sodium Phos-
phate, 500 mM NaCl, pH 7.4) using 20 kD molecular weight cut-off
(MWCO) Slide-A-Dialysis cassettes (Pierce). To prevent precipitationand to maximize the stability of the protein, 50 mM charged amino
acids L-Arg and L-Glu were added to all puriﬁcation buffers and dialysis
buffers (Golovanov et al., 2004). Dialysates were centrifuged at maxi-
mum speed (28,000g) in an Eppendorf 5804R centrifuge for 10 min at
4 °C and the supernatant was recovered to a fresh tube. The dialysates
were concentrated using vivaspin-20 concentrators with 30 kD
MWCO membranes (Vivaproducts, Inc.) and protein concentrations
were measured using a BCA protein assay kit (Thermo Scientiﬁc).
2.7. Western blots
The high sensitivity Western Breeze Chemiluminiscence Kit
(Invitrogen) with Alkaline Phosphatase (AP) conjugated anti-mouse
secondary antibody was used to perform Western blots. The Magic
Mark ladder (Invitrogen) was used for size determination. Ten microli-
ters of cell lysate or puriﬁed dialysate were added to 5 μl 4× LDS sample
buffer (Invitrogen) and 5 μl deionizedwater. Twentymicroliters of each
sample were heated at 70 °C for 10 min and 15 μl was loaded on a
NuPAGE® Novex 4–12% Bis-Tris Gel (Invitrogen). After 30 min of elec-
trophoresis at a constant voltage of 200 V, proteins were transferred
to a polyvinylidene diﬂuoride (PVDF) membrane (Invitrogen) using
an XCell SureLock® Mini-Cell and XCell II™ Blot Module Kit
(Invitrogen). Transfer was performed for 80 min at a constant voltage
of 30 V. Membranes were blocked with blocking buffer provided with
the Western Breeze Kit and stained with anti-V5 antibody and an AP
conjugated secondary antibody (Invitrogen) as per the instructions pro-
vided by themanufacturer. Chemiluminescencewas detected by expos-
ing Blue X-ray ﬁlm (ISC Bioexpress) to the blots for different exposure
times.
2.8. Ammonium sulfate precipitation
Thirty percent ammonium sulfate (AS) was used to precipitate pro-
teins in culture supernatants from the transfected cells. Fifty milliliters
of supernatant was used for each protein. The required quantity of am-
monium sulfate was calculated using the EnCor Biotechnology Inc.
webpage (http://www.encorbio.com/protocols/AM-SO4.htm). Salt
was added slowly while stirring the supernatant. Precipitation was per-
formed at 4 °C for 1 h. The suspension was centrifuged at 10,000g for
10 min at 4 °C to pellet the precipitated material. The supernatant was
poured off and the pellet was dissolved in a mixture of 50% phosphate
buffer with 50 mM L-Arg and L-Glu, pH 7.2 and 50% DMSO.
3. Results
3.1. Subcloning of MHC-I cDNAs
Most subclones had inserts with the correct sequences in the correct
orientation and contained the C-terminal 6× Histidine tag and V5 epi-
tope in-frame. The following MHC-I isoforms from the AH11 haplotype
were expressed in the two cell lines: BoLA-2*01802, BoLA-3*01701,
BoLA-NC1*00401 (splice variants with no transmembrane domain),
BoLA-NC1*00501 (full length protein with transmembrane domain),
BoLA-NC2*00102, BoLA-NC3*00101 and BoLA-NC4*00201 (Davies et
al., 2006).
3.2. Evaluation of cell surface expression by ﬂow cytometry
Transfected cell lineswere analyzed by ﬂow cytometry to determine
which bovineMHC-I proteinswere expressed on the cell surface. Twen-
ty-four hours post-transfection b20% of cells expressed the bovine
MHC-I transgenes. Expression of the transgenes increased to about
40% after selection with G418 for two weeks. Following FACS-sorting
of cell lines with cell surface expression of bovine MHC-I proteins a
high level of stable transgene expression, usually N90% positive cells,
was achieved. Due to lack of surface expression of the BoLA-
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Fig. 1. Flow cytometric analysis of FACS sorted murine P815 cells transfected with bovine MHC-Ia and MHC-Ib transgenes. Data for four anti-bovine MHC-I monoclonal antibodies are
shown: H1A, H6A, H58A and PT-85A (blue histograms). ColiS205D1 (red histograms) and W6/32 (blue histograms), which reacts with mouse MHC-I on the P815 cells, were used as
negative and positive antibody controls, respectively. Untransfected P815 cells served as a negative control for transgene expression (ﬁrst line). The MHC-Ia proteins BoLA-2*01802
and BoLA-3*01701, and MHC-Ib proteins BoLA-NC1*00501 and BoLA-NC3*00101 exhibited cell membrane expression on P815 cells. The BoLA-NC1*00401, BoLA-NC2*00102 and
BoLA-NC4*00201 proteins did not exhibit cell surface expression. With these three MHC-Ib proteins and the untransfected P815 cells the histograms for the antibody control,
ColiS205D1, and MCH-I speciﬁc antibodies are superimposed (dark red).
165P. Parasar et al. / Research in Veterinary Science 107 (2016) 161–170NC1*00401 and BoLA-NC2*00102 non-classical MHC-I proteins, it was
not possible to sort the cell lines expressing these transgenes.
The BoLA-2*01802, BoLA-3*01701, BoLA-NC1*00501 and BoLA-
NC3*00101 isoforms were expressed on the cell membrane in P815
cells (Fig. 1). All the monoclonal antibodies – H1A, H6A, H11A, H58A,
PT85A and IL-A88 – reacted with all of the bovine MHC-I proteins
(Table 1). However, antibody afﬁnity varied considerably with the dif-
ferent MHC-I isoforms. In transfected K562 cells the BoLA-2*01802,
BoLA-3*01701, BoLA-NC1*00501, BoLA-NC3*00101 and BoLA-
NC4*00201 isoforms were expressed on the cell surface (Fig. 2). Reac-
tivity of the H1A, H6A, H11A, H58A and PT85A antibodies on K562 cells
varied depending on the speciﬁc bovine MHC-I isoform expressed by
the transfected cell line (Table 2). For instance, the H6A and H11A anti-
bodies reacted very weakly with K562 cells expressing the BoLA-
2*01802 and BoLA-NC1*00501 proteins. Similarly, the H1A and PT-
85A antibodies did not react with the BoLA-NC4*00201 protein.3.3. Detection of protein expression by Western blotting
To conﬁrm that the transgenes were translated in the host cells, we
performed Western blotting of the crude cell lysates using an anti-V5
antibody (Invitrogen), which recognizes the V5 epitope in the C-termi-
nal peptide. We also tested an antibody directed against the C-terminal
His tag (Invitrogen) but this antibody did not work. A cell lineTable 1
Reactivity patterns of monoclonal antibodies on P815 cells transfected with cattle MHC-I gene
P815 cell line Monoclonal antibody
ColiS205 W6/32 H1A H6A
Untransfected − ++++ − −
BoLA-2*01802 − ++++ +++ +
BoLA-3*01701 − ++++ +++ ++
NC1*00401 − ++++ − −
NC1*00501 − ++++ ++++ ++
NC2*00102 − ++++ − −
NC3*00101 − ++++ ++++ ++
NC4*00201 − ++++ − −transfected with a plasmid encoding β-galactosidase, a 120 kD protein,
was used as a positive control. A lysate from untransfected cells was
used as a negative control. Lysates from all of the MHC-I transfected
cell lines contained proteins of approximately 45 kD that were bound
by the anti-V5 antibody. The BoLA-NC1*00401 protein, which has a
complete deletion of the transmembrane domain, was slightly smaller
than the otherMHC-I proteins. Sometimes there were non-speciﬁc pro-
tein bands seen in the crude lysates from the transfected cells but these
bands disappeared after puriﬁcation of the proteins with His GraviTrap
Columns (GE Healthcare; Figs. 3 and 4).3.4. Assessment of protein secretion by ammonium sulfate precipitation
MHC-I proteins in the culture supernatantswere detected by ammo-
nium sulfate precipitation followed by Western blotting with anti-V5
antibody (Figs. 5 and 6). Strong bandswere present for all of the surface
expressed MHC-I proteins: BoLA-2*01802, BoLA-3*01701, BoLA-
NC1*00501, BoLA-NC3*00101, and BoLA-NC4*00201 (only in K562
cells). This suggests that the MHC-I proteins were being shed from the
cell membrane at a signiﬁcant rate. There was a clear but fairly weak
band for BoLA-NC1*00401, which lacks the transmembrane domain,
in the supernatant from K562 cells suggesting that this may be a secret-
ed isoform. The BoLA-NC2*00102 protein apparently remained trapped
inside the cells as it was not detected in the culture supernatants.s.
H11A H58A PT85A IL-A88
− − − −
+ ++ ++ +++
++ +++ +++ +++
− − − −
++ +++ ++++ +++
− − − −
++ ++++ ++++ ++ ++++
− − − −
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Fig. 2. Flow cytometric analysis of MHC-Ia and MHC-Ib expression on transfected human MHC-I deﬁcient K562 cells. Reactivity of the W6/32, H1A, H6A, H58A and PT-85A monoclonal
antibodies with the bovine MHC-I proteins is shown (blue histograms). The ColiS205D1 monoclonal antibody was used as an antibody control (red histograms). Untransfected K562
cells served as a negative control for transgene expression (ﬁrst line). The MHC-Ia proteins BoLA-2*01802 and BoLA-3*01701, and MHC-Ib proteins BoLA-NC1*00501, BoLA-NC3*00101
and BoLA-NC4*00201 were expressed on the surface of transfected K562 cells. However, the BoLA-NC1*00401 and BoLA-NC2*00102 MHC-Ib proteins did not exhibit cell surface
expression. With these two proteins and the untransfected K562 cells the histograms for the antibody control, ColiS205D1, and MCH-I speciﬁc antibodies are superimposed (dark red).
167P. Parasar et al. / Research in Veterinary Science 107 (2016) 161–1704. Discussion
This study investigated the expression of bovine MHC-I isoforms
encoded at two MHC-Ia and four MHC-Ib loci in two different cell
lines, amurine cell line (P815) and a human cell line (K562). In addition,
we characterized the reactivity pattern of a panel of anti-MHC-I mono-
clonal antibodies on the expressed MHC-I proteins. We found that the
two classical isoforms BoLA-2*01802 and BoLA-3*01701 and the non-
classical isoforms BoLA-NC1*00501, BoLA-NC3*00101 and BoLA-
NC4*00201 were expressed as membrane associated proteins (Figs. 1
and 2). Other researchers have previously demonstrated expression of
classical bovine MHC-I proteins and the non-classical BoLA-
NC1*00101 protein (originally called N*50001) on the surface of
transfected P815 cells (Araibi et al., 2006; Ellis et al., 1999; Ellis et al.,
2005). It has also been reported that expression of BoLA-NC3*00101
was documented in the PhD thesis of N. Barker (Barker, 1996; Birch et
al., 2008a). A novel ﬁnding in our study was that the BoLA-NC4*00201
heavy chain remained intracellular in P815 cells but exhibited surface
expression on K562 cells (Figs. 1 and 2). It is likely that human β2m
can associate with the BoLA-NC4*00201 heavy chain thereby allowing
peptide binding and cell surface expression, while murine β2m does
not form a functional heterodimer with this bovine MHC-I heavy
chain. The percent amino acid identity for the mature β2m peptides is
75.8% for bovine (GenBank Acc. # XM_001251107 and X69084) and
human (GenBank AF072097), 67.7% for bovine and murine (GenBankTable 2
Reactivity patterns of monoclonal antibodies on K562 cells transfected with cattle MHC-I gene
K562 cell line Monoclonal antibody
ColiS205 W6/32 H1A
Untransfected − − −
BoLA-2*01802 − ++++ +++
BoLA-3*01701 − +++ ++++
NC1*00401 − − −
NC1*00501 − ++++ ++
NC2*00102 − − −
NC3*00101 − ++++ ++
NC4*00201 − +++ −NM_009735), and 69.7% for human andmurine β2m. It seems plausible
that this level of variation could inﬂuence pairing with the MHC class I
heavy chain and/or the tertiary structure of the heterodimer. An alter-
native explanation is that murine P815 cells don't contain an appropri-
ate peptide ligand for BoLA-NC4*00201.
TwoMHC-Ib proteins, the BoLA-NC1*00401 protein (formerly called
BoLA-N*50501), which was expressed as a BoLA-NC1 splice variant that
lacks the transmembrane domain (Davies et al., 2006), and the BoLA-
NC2*00102 protein were expressed as intracellular proteins in
transfected cells (Figs. 3 and 4) but were not present on the cell mem-
brane (Figs. 1 and 2). Ellis and colleagues (Ellis et al., 1996) attempted
to express a different BoLA-NC2 allele (BoLA-NC2*00101 referred to as
HD15 in this paper) in P815 cells and failed to detect any protein
expressed at the cell surface even when they co-transfected the cells
with bovine β2m. We agree with Birch et al. (2008a) that intracellular
retention of the heavy chain in multiple cell lines suggests that BoLA-
NC2*00101 may require a speciﬁc peptide for cell surface expression,
as is the case with HLA-E (Braud et al., 1998b; Lee et al., 1998; Sala et
al., 2004). The BoLA-NC2*00102 protein has an intact transmembrane
domain (Davies et al., 2006), suggesting that this is a membrane associ-
ated rather than a secreted protein. Furthermore, we found no evidence
for secretion of the BoLA-NC2*00101 heavy chain in our ammonium
sulfate precipitation experiments (Figs. 5 and 6). Further research is
needed to determine the requirements for surface expression of BoLA-
NC2 and whether the BoLA-NC2 gene is an orthologue of HLA-E.s.
H6A H11A H58A PT85A
− − − −
+ + ++ ++
++++ ++++ ++++ ++++
− − − −
+ + + ++
− − − −
++ ++ +++ +
++++ ++++ ++++ −
Fig. 3. Expression of recombinant MHC-Ia and MHC-Ib proteins in mouse P815 cells.
Puriﬁed proteins were detected on a Western blot with anti-V5 antibody. Beta-
galactosidase was expressed as a positive transfection control.
Fig. 5. Identiﬁcation of bovine MHC-Ia and MHC-Ib proteins released in P815 cell culture
supernatants. Ammonium sulfate-precipitated proteins from transfected murine P815
cell culture supernatants were detected by Western blot with anti-V5 antibody.
168 P. Parasar et al. / Research in Veterinary Science 107 (2016) 161–170As far as we know, we are the ﬁrst to investigate secretion of bovine
MHC-I proteins. Immunoblotting experiments with proteins precipitat-
ed from culture supernatants showed that all of the surface expressed
MHC-I proteins were shed or released from the cell membrane (Figs. 5
and 6). An anti-V5 monoclonal antibody was used for the Western
blots to detect the bovine MHC-I proteins. Consequently, only full-
length proteins that were shed from the cell membrane and retained
their cytoplasmic tail with its 3′ histidine tag and V5 epitope were de-
tected. MHC-I proteins that were enzymatically cleaved from the cell
membrane would not be detected with this antibody.
The presence of multiple BoLA-NC1 splice variants is reminiscent of
what has been observed with the HLA-G and Qa-2 genes (Comiskey et
al., 2003; Davies et al., 2006; Ellis et al., 1986; Hunt et al., 2005). Because
we used a splice variant of the BoLA-NC1*00401 gene that lacks a trans-
membrane domain, we predicted that this transgene would encode a
secreted protein. Although there was noticeable secretion of the BoLA-
NC1*00401 protein by transfected K562 cells (Fig. 6) the level of secre-
tion was fairly low compared to the level of shedding of membrane as-
sociated MHC-I proteins. One explanation for the low level of secretion
is that this cell linewas not enriched for high expressing cells usingﬂuo-
rescence activated cell sorting. It is also possible that secretion of BoLA-
NC1 splice variants ismore efﬁcient in certain specialized cell types such
as trophoblast cells.
Identiﬁcation of monoclonal antibodies that distinguish different
MHC isoforms, particularly the products of different MHC-I genes, isFig. 4. MHC-Ia and MHC-Ib proteins were expressed in transfected K562 cells. Puriﬁed
recombinant proteins were detected on a Western blot with anti-V5 antibody.
Untransfected K562 cells were included as a negative control.important for identiﬁcation of speciﬁc isoforms on the surface of spe-
cialized cells such as trophoblast cells and for the detection of secreted
or shedMHC-I proteins that could act as immunomodulatorymolecules.
The monoclonal antibodies that were tested varied in their afﬁnity for
the different MHC-I isoforms and in some cases reacted slightly differ-
ently in the two cell lines. For the two classical MHC-I proteins there
were some clear differences in antibody reactivity (Tables 1 and 2). All
of the antibodies, with the exception of W6/32, had very high afﬁnity
for the BoLA-3*01701 protein expressed on K562 cells. The percentage
of cells staining positive for BoLA-3*01701 was somewhat lower in
P815 cells but it is likely that this was due to a lower level of protein ex-
pression on the cell surface rather than lower antibody afﬁnity. The
BoLA-2*01802 protein stained strongly with W6/32, moderately well
with H1A and IL-A88, relatively poorly with H58A and PT85A, and
very weekly with H6A and H11A in both cell lines. Two of the non-clas-
sical MHC-I proteins, BoLA-NC1*00501 and BoLA-NC3*00101 were
expressed at amuch higher level in P815 cells than in K562 cells. In con-
trast, the BoLA-NC4*00201 isoform was expressed at a high level in
K562 cells and not at all in P815 cells. The BoLA-NC1*00501 protein
was bound with very high afﬁnity by W6/32 in the K562 cells, which
had relatively low protein expression, and showed strong reactivity
with H1A and PT85A, particularly in the P815 cells. The BoLA-
NC3*00101 protein was recognized particularly strongly by W6/32 in
K562 cells and by H58A in both cell lines, but H1A, H6A, H11A and IL-
A88 also reacted strongly with this MHC-I protein on P815 cells. The
BoLA-NC4*00201 protein was recognized strongly by H6A, H11A and
H58A and somewhat less strongly by W6/32. Interestingly, neither the
H1A or PT85A antibodies recognized this protein (Fig. 2).Fig. 6. Detection of bovine MHC-Ia and MHC-Ib proteins released in K562 cell culture
supernatants. Proteins were precipitated using (NH4)2 SO4 and detected with anti-V5
antibody on a Western blot.
169P. Parasar et al. / Research in Veterinary Science 107 (2016) 161–170In conclusion, this comprehensive study demonstrated cell surface
expression of three non-classical MHC-I proteins – BoLA-NC1*00501,
BoLA-NC3*00101 and BoLA-NC4*00201 – but found no evidence for
cell surface expression of two other MHC-Ib proteins: BoLA-
NC1*00401 and BoLA-NC2*00102. The BoLA-NC1*00401 isoform that
was used in our experiments is a BoLA-NC1 splice variant lacking a
transmembrane domain. Consequently, we had hypothesized that this
construct would code for a secreted protein. Our data support secretion
of BoLA-NC1*00401, and also shedding and/or secretion of all mem-
brane associated MHC-I proteins tested. Lack of surface expression of
BoLA-NC2*00102 is particularly interesting. It appears that this highly
conserved, virtually monomorphic, MHC-Ib protein has special require-
ments for cell surface expression such as the presence of a particular
peptide ligand. This is intriguing because it implies that the BoLA-NC2
gene could be a functional orthologue of HLA-E. Future objectives in-
clude: (1) identiﬁcation of the receptors that bind bovine non-classical
MHC-I proteins, (2) determination of the requirements for cell surface
expression of the BoLA-NC2 protein, and (3) measurement of the level
of secretion or shedding of soluble MHC-I proteins during bovine
pregnancy.
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